This webinar intends to discuss the current market in the advanced therapeutic medicinal product (ATMP) space, with a particular focus on the challenges specific to this sector, and how those impact on aspects such as due diligence, collaboration, funding and deals.
These topics will be explored using case studies from two ATMP companies at different growth stages, Quell Therapeutics and NK:IO. Additional insights on access to technology, and issues on manufacturing and supply chain being provided by our speaker from the Cell and Gene Therapy Catapult, which works to support companies in this sector.
Click here to find out more about the Speakers.
- Matthew Garner - Head of IP, Cell and Gene Therapy Catapult
- Jodie Albutt - VP of IP, Quell Therapeutics
- Michael Hunt - CEO of NK:IO
- Kerstin Papenfuss - Director, Pharma, Deep Science Ventures
- Anna Gregson - Partner, Mathys & Squire LLP
This event is free to participants.